Skip to main content
. 2019 Mar 20;11(3):393. doi: 10.3390/cancers11030393
AP-1 activator protein-1
BAP-1 BRCA1-associated protein 1
BARD-1 BRCA1-associated RING domain protein 1
BRCA-1 Breast cancer type 1 susceptibility protein
ChIP chromatin immunoprecipitation
EMT epithelial-mesenchymal transition
ERα estrogen receptor alpha
EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit
FOX forkhead BOX
FOXK1 forkhead box K1
FOXK2 forkhead box K2
FOXO3a forkhead box O3
FHA forkhead associated domain
Gsk3 glycogen synthase kinase 3
HCC hepatocellular carcinoma
HIF1α hypoxia-inducing factor 1 alpha
HIV human immunodeficiency virus
HDAC histone deacetylase
HPV human papillomavirus
IL-2 interleukin-2
ILF interleukin-enhancer binding factor
MBD methyl binding domain protein
mTOR mammalian target of rapamycin
NCoR/SMRT nuclear receptor co-repressor/silencing mediator for retinoid or thyroid-hormone receptors
NFAT nuclear factor of activating cells
NLS nuclear localization signal
NNMT nicotinamide N-methyltransferase
NURD nucleosome remodeling deacetylase
PR-DUB Polycomb repressive deubiquitinase
REST RE1-silencing transcription factor
SOX9 Sex-determining region Y box 9
TCGA The Cancer Genome Atlas